Saier M H, Boyden D A
Mol Cell Biochem. 1984;59(1-2):11-32. doi: 10.1007/BF00231303.
Investigations in numerous laboratories have characterized a salt transport system, present in many animal cell types, which catalyzes the transmembrane transport of NaCl and KCl in a tightly coupled process. The system is inhibited by loop diuretics such as furosemide and bumetanide. This transport system has been designated the loop diuretic-sensitive NaCl/KCl symporter. It has been implicated in transepithelial salt secretion and absorption as well as in cell volume regulation, and it may be defective in patients suffering from essential hypertension. This review serves to evaluate research conducted to date regarding the mechanism, mode of regulation, and physiological significance of the transport system. Ion binding specificities and absolute binding constants for all three naturally occurring ions have been determined in one cell system, the MDCK kidney epithelial cell line. In that same cell line, substrate binding was shown to exhibit apparent cooperativity. although a few reports suggest unidirectional transport of ions via this system under certain conditions, the consensus of reports indicates fully reversible, bidirectional salt transport with the direction of net flux determined by the magnitudes of the gradients of the three transported ions. Growth of cells in media containing a low concentration of K+ (less than 0.25 mM) allows selection of mutants lacking or defective in the symporter. Kinetic analyses with the MDCK cell line have shown that the symporter catalyzes accelerative exchange transport. However, exchange transport of one ion in the absence of one of the other two ionic substrates has not been documented. Comparison with other well-characterized transmembrane transport systems has shown that the characteristics of the NaCl/KCl symporter most resemble those of two-species facilitators (chemiosmotically-coupled symporters) found in prokaryotes and eukaryotes alike. these two-species facilitators consist of a single transmembrane protein and may function by a carrier-type mechanism as originally proposed by Peter Mitchell. A molecular model for the NaCl/KCl symporter is presented and discussed. Activation of symport activity requires ATP and probably occurs by a protein kinase-catalyzed mechanism. In some cell types activation is cyclic AMP dependent. ATP hydrolysis is not stoichiometric with transport. Phosphorylation of an integral membrane protein with an apparent size of 240 000 daltons correlates with activation of transport. It is postulated that this protein is the loop diuretic-sensitive NaCl/KCl symporter.
众多实验室的研究已对一种盐转运系统进行了特性描述,该系统存在于多种动物细胞类型中,能在紧密偶联的过程中催化氯化钠和氯化钾的跨膜转运。该系统会被速尿和布美他尼等袢利尿剂抑制。这种转运系统被命名为对袢利尿剂敏感的氯化钠/氯化钾同向转运体。它与跨上皮盐分泌和吸收以及细胞体积调节有关,原发性高血压患者的该系统可能存在缺陷。这篇综述旨在评估迄今为止关于该转运系统的机制、调节方式和生理意义的研究。在一种细胞系统——MDCK肾上皮细胞系中,已确定了所有三种天然存在离子的离子结合特异性和绝对结合常数。在同一细胞系中,底物结合表现出明显的协同性。尽管有一些报告表明在某些条件下离子通过该系统进行单向转运,但报告的共识表明是完全可逆的双向盐转运,净通量方向由三种转运离子的梯度大小决定。在含有低浓度钾离子(小于0.25 mM)的培养基中培养细胞,可筛选出缺乏同向转运体或其功能有缺陷的突变体。对MDCK细胞系的动力学分析表明,同向转运体催化加速交换转运。然而,在没有另外两种离子底物之一的情况下一种离子的交换转运尚未得到证实。与其他已充分表征的跨膜转运系统的比较表明,氯化钠/氯化钾同向转运体的特性最类似于在原核生物和真核生物中都发现的双物种促进剂(化学渗透偶联同向转运体)。这些双物种促进剂由单一跨膜蛋白组成,可能通过彼得·米切尔最初提出的载体型机制发挥作用。本文提出并讨论了氯化钠/氯化钾同向转运体的分子模型。同向转运活性的激活需要ATP,可能通过蛋白激酶催化的机制发生。在某些细胞类型中,激活是依赖环磷酸腺苷的。ATP水解与转运不是化学计量关系。一种表观大小为240000道尔顿的整合膜蛋白的磷酸化与转运激活相关。据推测,这种蛋白就是对袢利尿剂敏感的氯化钠/氯化钾同向转运体。